Pharma & Medical Devices

Pharmaceuticals and Medical Devices: Why the Building Is Part of the Licence

GT Realty Insights · 8 min read · Bhiwani, Haryana

In most sectors the factory is where compliance happens. Here, the factory is the compliance — which changes how you choose a site.

The building is part of the licence

In most sectors the factory is where compliance happens. In pharmaceuticals and medical devices the factory is the compliance. Layout, finishes, air handling, water systems and material flow are inspected as part of licensing — which means the building cannot be chosen first and validated afterwards.

That reframes site selection. You are not looking for a shed that can be adapted. You are looking for a plot and a developer who will build to a drawing your regulatory consultant has already signed off, and who understands that a change to a door position is not a minor variation.

US$ 50 bn
projected medical devices market by 2030
16.4%
CAGR to 2030
70–80%
of devices still imported
+88%
device export growth, FY25

An import-substitution story

India's medical devices market stood at about US$ 15.2 billion in 2025 and is projected to reach US$ 50 billion by 2030, a 16.4% CAGR. The more interesting number for a domestic manufacturer is that India still imports 70–80% of its medical devices. That gap is the whole commercial case.

Exports are moving too: device exports rose 88% to ₹31,120 crore in FY25, with a stated potential of ₹1,69,000 crore by FY30. Diagnostic imaging alone was ₹17,606 crore in 2025.

India medical devices market size (US$ billion)
2023 (US$ bn)15.352025 (US$ bn)15.22030 projected (US$ bn)50
Source: IBEF, Medical Devices industry in India. Figures as published; verify before relying on them.
Pharmaceuticals and medical devices — a named thrust sector
Policy note

A named thrust sector

Thrust-sector status is what unlocks the capital investment subsidy under the 2026 policy. It is worth confirming your product classification early — it changes the arithmetic.

What has to be designed in

Unidirectional material and personnel flow

Raw material, personnel, work in progress and waste must not cross. That is a plan-level constraint, and it is the single most common reason a converted building fails inspection.

Coved, washable finishes

Wall-to-floor junctions coved, surfaces non-shedding and cleanable, no exposed services in classified areas. These are construction decisions, not fit-out decisions.

Water and air as utilities in their own right

Purified water generation and distribution, and HVAC with defined filtration and pressure cascades, need plant space and structural provision. Allow for them in the footprint from the beginning.

Why a pharma or device facility is designed, not adapted
ElementWhy it is a building decisionWhen to fix it
Material & personnel flowCannot be corrected after walls are upPlan stage
Floor-to-wall covingRequires the right substrate and detailingConstruction
HVAC pressure cascadeNeeds plant space and ceiling voidDesign
Purified water plantFootprint, drainage and accessDesign
Change rooms & airlocksConsume floor area and dictate circulationPlan stage
Waste egressMust not cross the clean routePlan stage
Indicative guidance for site evaluation. Regulatory requirements vary by product class — confirm with your licensing consultant.

Where the policy sits

Pharmaceuticals & Medical Devices is thrust sector 05 of the nine named in Haryana’s Progressive MSME & Export Promotion Policy 2026, notified on 29 July 2026 in supersession of HEEP 2020 and the MSME Policy 2019. Thrust-sector status is what unlocks the capital investment subsidy; sectors outside the list can still claim the infrastructure and employment provisions, but not that one.

The bigger change is how location is graded. The 2026 policy sets the rate by the status of the land rather than by how developed the district is — four categories, Core through Prime/Focus. Our industrial parks fall in Prime/Focus, the top band: 30% capital investment subsidy up to ₹4 crore, a 100% stamp duty refund on the land, 70% of Net SGST reimbursed for seven years, and 7% interest subsidy on term loans up to ₹25 lakh a year. The full schedule is here.

One line worth reading twice: total incentives for any single project are capped at 100% of fixed capital investment. The schemes stack, but not without limit.

Siting this in Bhiwani

Where a pharma or device unit lands in Bhiwani

This sector needs land and a builder rather than a ready shed. GT Realty offers built-to-suit at Prestige, Auron and Unity — you bring the validated drawing, we build to it, on metered infrastructure that a regulatory audit can trace.

Frequently asked

Can I convert a ready-to-move shed into a licensed facility?

Sometimes, but it is rarely the cheaper route. Material and personnel flow, coving and pressure cascades are far less expensive designed in than retrofitted. Built-to-suit is usually the right answer for this sector.

Do you build to a consultant's drawing?

Yes. Built-to-suit is available at Prestige, Auron and Unity. Bring the drawing and the load case; we will tell you honestly what we can and cannot build.

Is pharma covered by the Haryana thrust sectors?

Yes — Pharmaceuticals and Medical Devices is thrust sector 05 under the 2026 policy. At Prime/Focus that is 30% capital subsidy up to ₹4 crore and a 100% stamp duty refund. Details here.

What about water availability?

A fair question, and one to ask early. Purified water generation needs a reliable raw supply, and the policy excludes certain high-water-consumption units in notified Dark Zones. Raise it at enquiry stage and we will give you a straight answer.
← All insightsElectronics & InstrumentsRubber & Plastic

Planning a unit in this sector?

Tell us your process, space requirement and timeline. We respond with plot options, shed availability and honest guidance on whether our parks suit your operation.

Enquire Now → Incentives